Cactus

Other Names

Bajtar tax-XewkBarbary figbelesCactaceaecactus appleCactus decumanusCactus ficus-indicacactus fruitCactus opuntiacactus pearChardon d'IndechumberaFeigenkaktusfichi d'Indiafico d'Indiaficuriniafig opuntiafiga de morofigo di Indiafigu moriscafiguier à raquettesfiguier d'IndeFiguier de Barbariefigumoriscahigo chumbohiguera de chumbohiguera de palaIndian figIndian fig opuntiaKaktusfeigemission cactusmission prickly pearnōchtlinopalnopal cactusNopaleanopalesnopalitosnōpallinostleOpuntiaOpuntia amyclaeaOpuntia cordobensisOpuntia decumanaOpuntia ficus-indicaOpuntia ficus-indica (L.) Mill.Opuntia fragilisOpuntia gymnocarpaOpuntia hispanicaOpuntia maximaOpuntia megacanthaOpuntia paraguayensisOpuntia streptacanthaOpuntia tunaOpuntia vulgarispaddle cactuspencaPlatyopuntia ficus-indicaprickly pearprickly pear cactussabbarsabrasmooth mountain prickly pearspineless cactussweet prickly peartunatuna cactustungiTurksvyTurksvygViikunaopuntiaΦραγκόσυκοウチワサボテン보검선인장

Synopsis

Cactus (Opuntia ficus-indica and Related Species) as a Dietary Supplement and Medicinal Ingredient

1. Identity: Botanical Classification, Names, and Preparations

Opuntia ficus-indica (L.) Mill., commonly called prickly pear or nopal cactus, belongs to the dicotyledonous angiosperm Cactaceae family and is characterized by its remarkable adaptation to arid and semi-arid climates in tropical and subtropical regions of the globe. The Cactaceae family includes about 1,500 species of cactus.

O. ficus-indica is a tropical and subtropical plant that can grow in arid and semi-arid climates, with a geographical distribution encompassing Mexico, Latin America, South Africa, and Mediterranean countries.

The plant is sold and studied under a wide variety of common names. These include Barbary pear, cactus pear, Indian fig, Indian pear, nopal, and prickly pear. In the scientific supplement literature, the species designation Opuntia ficus-indica (abbreviated OFI) is used. The flat, pad-like stems are called cladodes (or nopales/nopalitos when used as food), while the edible fruit is called the prickly pear or tuna.

Other species within the genus Opuntia appear in the research literature, including Opuntia robusta, Opuntia streptacantha, and Opuntia joconostle, though O. ficus-indica is the most domesticated and studied species, with several reports describing the main compounds found in cladodes, flowers, and fruits.

Common Forms and Preparations

O. ficus-indica fruits, stems, seeds, and cladodes have been traditionally used in folk medicine to prevent and cure chronic diseases. In the modern supplement market, cactus preparations appear in several forms documented in the clinical literature:

Fresh or steamed cladodes (nopal pads): consumed directly as food, typically 500 g portions in clinical trials.
Dehydrated/dried cladode powder: encapsulated or taken as powder, with trial doses of 50 g cladode powder or 10.1 g dehydrated extract in capsule form.
Standardized patented extracts: including NeOpuntia (a dehydrated extract of O. ficus-indica leaves) and OpunDia, used in randomized controlled trials at specific doses such as 1.6 g per meal.
Fresh fruit pulp: used in oxidative stress studies at doses of 250 g once or twice daily.
Juice and liquid extracts
Flower decoctions

A meta-analysis of five blinded randomized controlled trials evaluated various dose forms of O. ficus-indica at daily dosages ranging from 400 mg to 15 g for durations of 6 weeks to 2 years.

2. Traditional and Historical Use

Mesoamerican Origins

Mesoamericans cultivated Opuntia ficus-indica at least 9,000 years ago, at about the same time Eurasian peoples began domesticating wheat. The importance of cacti in Mesoamerican cultures can be recognized in pre-Columbian codices, which contain many toponymic glyphs referring to the names of cacti or their parts. Among the most famous are Tenochtitlán ("place of stony prickly pears" in Náhuatl), the original name of Mexico City, and Nochistlán ("place of prickly pears" in Náhuatl), in the state of Oaxaca.

Historical information on utilization of cacti can be found in La Historia General y Natural de las Indias, published by Oviedo y Valdés in 1535. The Barberini Codex from 1552 includes information on medicinal utilization of Tlatocnochtli, a species of Opuntia, and a description of Teonochtli, identified as Stenocereus sp.

Cactus pears (Cactaceae) are an essential element of Mesoamerican botanical history. For centuries the Aztecs and many other Mexican indigenous groups used ripe fruits and the nopales (or nopalitos, tender cladodes) both as a food and a medicine.

Therapeutic Uses in Indigenous and Folk Medicine

For millennia, Native American peoples placed prickly pear flesh on wounds or burns to promote healing and reduce swelling. These communities used cactus pads and fruit to treat rheumatism, mumps, edema, dysentery, indigestion, and a variety of other ailments.

Nopal (Opuntia ficus-indica) stems have been traditionally used in Mexico for the treatment of diabetes.

Mediterranean and Iberian Introduction

Because the oldest Arabic medicine treatises do not mention cactus, it is generally accepted that Spain might have introduced the nopal fig tree in the 15th century from Central America after the conquest of the northwest of Africa. Traditions linked to this cactus in the Mediterranean included the production of a red dye obtained from the fruits and the use of a decoction of dried flowers for diuretic purposes. In Spain, the flowers were used to treat seizures in children in the 18th century.

South American (Andean) Traditions

A distinct cactus species, Echinopsis pachanoi (San Pedro cactus), has an independent tradition of medicinal use in South America. It has a long history of being used in Andean traditional medicine, and archaeological studies have found evidence of use going back two thousand years, to the Moche, Nazca, and Chavín cultures. It has been used for healing and religious divination in the Andes Mountains region for over 3,000 years. In 2022, the Peruvian Ministry of Culture declared the traditional use of San Pedro cactus in northern Peru as cultural heritage. This species contains mescaline and other alkaloids and is distinct in chemical profile and traditional application from Opuntia species; its pharmacological properties are not the subject of most dietary supplement research.

3. Key Constituents and Active Compounds

Opuntia ficus-indica fruits represent a complex food matrix containing betalains, polyphenols, carotenoids, soluble fiber, functional amino acids, vitamins, and minerals.

Betalains

Prickly pears are rich in phenols, flavonoids, betaxanthins, and betacyanins, which favor a healthy status through hypoglycaemic and hypolipidemic actions, and antioxidant properties. Remarkably, among existing natural pigments, betalains are present in high amounts in cactus. The two principal subclasses are the red-violet betacyanins (including betanin) and the yellow betaxanthins (including indicaxanthin). Biological effects may be due to the synergistic action of betalains (tyrosine-derived pigments), flavonoids, and other biologically active components.

Flavonoids and Polyphenols

The presence of antioxidants (flavonoids, ascorbate), pigments (carotenoids, betalains such as indicaxanthin), or phenolic acids has been reported in all Opuntia products, including seeds, roots, pears, cladodes, or juice. Key identified flavonoids from OFI fruits include quercetin, kaempferol, and isorhamnetin. Gallic acid exerts cytotoxic activity against tumoral cells from leukemia, lung, and prostate cancer origins in experimental models. Opuntia ficus-indica cladodes are rich in nicotiflorin which, through anti-inflammatory and neuroprotective mechanisms, was shown in preclinical models to reduce brain infarct size.

Fiber: Pectin, Mucilage, and Soluble Fiber

Opuntia is widely known for its production of mucus (mucilage), which is a form of dietary fiber. The high total fiber content of Opuntia fruits includes high amounts of pectin and mucilage. The coagulant, thickening/gelling, and polyelectrolytic activities of OFI are mainly attributable to its polygalacturonic acid content (pectin).

Vitamins and Other Nutrients

The nutritional value of cactus pear fruit mainly rests on its content of ascorbic acid, vitamin E, carotenoids, fibers, amino acids, and large amounts of glucose and fructose.

Established Mechanisms of Action

Experimental evidence suggests that the constituents of OFI interact with key molecular networks implicated in metabolic syndrome pathophysiology, including redox-sensitive pathways (NRF2), inflammatory signaling (NF-κB), energy-sensing regulators (AMPK), and lipid metabolism PPAR-α dependent mechanisms.

With respect to glucose metabolism specifically: certain cactus constituents such as flavonoids may inhibit intestinal α-glucosidase activity, thereby delaying carbohydrate digestion and absorption. Other research suggests they may reduce endogenous glucose output by modulating the activity of key hepatic gluconeogenic enzymes. At the molecular level, studies suggest that cactus bioactive compounds can promote GLUT4 translocation and enhance insulin signaling through AMPK, PI3K/Akt, and MAPK pathways. They may also modulate gut microbiota and short-chain fatty acid (SCFA) metabolism, indirectly improving glucose homeostasis.

Regarding inflammation: in human intestinal epithelial cancer cells (Caco-2) stimulated by IL-1β, co-treatment with indicaxanthin (a pigment from OFI) prevents activation of NOX-1 and NF-kB and attenuates the rise in inducible NO synthase. These data suggest that cactus dietary pigments may directly influence intestinal inflammatory mechanisms. In human chondrocyte cultures stimulated with IL-1β, lyophilized extracts of OFI cladodes reduce the production of nitric oxide (NO), glycosaminoglycans, prostaglandin-E2 (PGE-2), and reactive oxygen species.

4. Scientific Evidence by Area of Use

4.1 Glycemic Control and Type 2 Diabetes

This is the most extensively studied area of clinical application for cactus supplements.

Several randomized controlled and crossover trials have consistently reported that the ingestion of Opuntia ficus-indica cladodes (nopal) reduces postprandial glycemic excursions in patients with type 2 diabetes.

Specific trials by Frati-Munari and colleagues are frequently cited. Frati and colleagues measured the hypoglycemic effect of 500 g of broiled nopal stems in subjects with diabetes in several small clinical trials. These trials confirmed the effectiveness of nopal to lower glucose and insulin levels in individuals with diabetes, with the mean reduction of glucose reaching 17.6 ± 2.2% and serum insulin 50.2 ± 8.0% of basal values at 180 minutes.

The role of preparation form is critical. Studies exploring other forms of nopal such as capsules or juice did not demonstrate any significant changes in serum glucose level. This was confirmed by earlier work: a dehydrated nopal extract did not reduce fasting glycemia in diabetic subjects; nevertheless, the extract diminished the increase of serum glucose which followed a dextrose load — peak serum glucose was 20.3 ± 18.2 mg/dL lower in the nopal group than in the control group (P < 0.025).

Bacardí-Gascón et al. demonstrated that adding steamed nopal to a traditional Mexican breakfast significantly attenuated postprandial glucose area under the curve (AUC) without altering fasting glucose.

A systematic review covering glycemic outcomes found: there is currently a lack of evidence to support the recommendation of using Opuntia spp. fruit products as an alternative or complementary therapy in the reduction of risk or management of type 2 diabetes mellitus. The cladode does, however, show promise in potential glucose-lowering effects which warrant further investigation.

In one experiment, cladode powder (50 g) in healthy participants significantly lowered serum glucose (p < 0.001) and produced a glycemic index score of 32.5 ± 4.0, and an insulinemic index of 36.1 ± 6.1, upon ingestion.

Evidence strength: Preliminary to moderate. Evidence supports a postprandial glucose-lowering effect of fresh or steamed cladodes in people with type 2 diabetes, but study populations are small, many trials are not blinded, and long-term effects on HbA1c and fasting glucose remain unclear. The preparation form appears to matter substantially. Fruit preparations have not shown consistent effects.

4.2 Lipid Profile and Cardiovascular Risk

A study analyzed the effects of prickly pear pectin from Opuntia robusta on lipid and glucose metabolism in non-diabetic and non-obese males (37–55 years old) with primary hypercholesterolemia or combined hyperlipidaemia. An eight-week intervention replacing 625 kJ with prickly pear pulp (250 g/day) revealed decreases in serum total cholesterol (−12%), LDL-cholesterol (−15%), apolipoprotein B (−9%), triglycerides (−12%), fibrinogen (−11%), glucose (−11%), insulin (−11%), and uric acid (−10%).

In a study of women with metabolic syndrome (N=68), consumption of dried leaves from O. ficus-indica as a dietary supplement (NeOpuntia 1.6 g per meal for 6 weeks) was associated with a rapid increase in circulating HDL cholesterol level, a decrease in LDL cholesterol, and a slight decrease in triglycerides. These results suggest that prickly pear may exert a hypocholesterolemic effect.

A systematic review examining various dosages of prickly pear fruit and cladode consumption in healthy and obese patients, as well as in patients with metabolic illnesses, found that prickly pear fruit consumption was associated with significant reductions in total cholesterol versus placebo (P < 0.05) in all but one included study.

A systematic review and meta-analysis (Onakpoya 2015) drew on 5 blinded RCTs. Analysis of data from studies identified through April 2014 revealed a nonsignificant difference in body weight and waist circumference between cactus pear and controls, with statistically significant reductions in BMI, percent body fat, blood pressure, and total cholesterol. However, heterogeneity was high, and risk of bias was highly variable. Effect sizes for BMI and percent body fat reductions were small and not clinically important.

In an assessment of health claims, the European Food Safety Authority concluded that a cause-and-effect relationship between the consumption of NeOpuntia and the claimed beneficial effects on blood lipid profile had not been established.

Evidence strength: Weak to preliminary. Individual trials show lipid-modifying effects, but the overall evidence base is heterogeneous, with small samples and variable study quality. Regulatory bodies such as EFSA have not validated a health claim for lipid reduction.

4.3 Antioxidant and Anti-Inflammatory Effects

The prickly pear has a high antioxidant activity attributed to ascorbic acid, carotenoids, flavonoids, polyphenols, and betalains. The antioxidant activity is twice as high as that of other fruits such as pears, apples, tomatoes, bananas, and white grapes, and has similar levels to red grapes and grapefruit.

A key human study by Tesoriere et al. (2004) tested the antioxidant effects in vivo. Cactus pear fruit contains vitamin C and characteristic betalain pigments whose radical-scavenging properties and antioxidant activities had been shown in vitro. In a randomized, crossover, double-treatment study, 18 healthy volunteers received either 250 g fresh fruit pulp or 75 mg vitamin C twice daily for 2 weeks, with a 6-week washout period between treatments. Ingestion of OFI fruit produced a decrease in markers of oxidative stress, inhibited LDL oxidation, and resulted in increased oxidative haemolysis resistance of red blood cells in ex vivo experiments.

In a comparative study in healthy volunteers (N=18) and a study of patients with familial isolated hypercholesterolemia (N=15), short-term supplementation with 250 g of fresh fruit pulp once or twice daily reduced oxidative damage to lipids and improved oxidative stress status.

Evidence strength: Preliminary. The human antioxidant evidence is based on small, short-duration trials. Cell-culture and animal findings are extensive, but translation to clinical benefit has not been established.

4.4 Alcohol Hangover Symptoms

One well-designed trial specifically investigated this use. An extract of the OFI plant diminishes the inflammatory response to stressful stimuli. In this double-blind, placebo-controlled, crossover trial, 64 healthy, young adult volunteers were randomly assigned to receive OFI (1600 IU) and identical placebo, given 5 hours before alcohol consumption. During 4 hours, subjects consumed up to 1.75 g of alcohol per kilogram of body weight.

Fifty-five subjects completed both the OFI and placebo arms of the study. Three of the 9 symptoms — nausea, dry mouth, and anorexia — were significantly reduced by OFI (all P < .05). Overall, the symptom index was reduced by 2.7 points on average (95% CI, −0.2 to 5.5; P = .07), and the risk of a severe hangover (≥18 points) was reduced by half (odds ratio, 0.38; 95% CI, 0.16–0.88; P = .02).

C-reactive protein levels were strongly associated with hangover severity; the mean symptom index was 4.1 (95% CI, 1.2–7.1; P = .007) higher in subjects with morning C-reactive protein levels greater than 1.0 mg/L.

An extract of the OFI plant has a moderate effect on reducing hangover symptoms, apparently by inhibiting the production of inflammatory mediators. This trial was conducted with research support from Extracts Plus, San Diego, CA — a financial conflict of interest that limits interpretation.

Evidence strength: Single well-designed RCT showing moderate effect on a subset of hangover symptoms. The primary symptom index reduction did not reach conventional significance (P = .07). Replication in independent studies is needed. Industry funding is a noted limitation.

4.5 Body Weight and Obesity

Clinical trials examining the effect of OFI on body weight and composition and lipid profile have been conducted, but the effectiveness of this supplement as a weight loss aid has not been established.

In a 6-week, randomized, double-blind, placebo-controlled study (N=68), supplementation with NeOpuntia, a patented dehydrated extract of Opuntia ficus-indica leaves, taken at 1.6 g/meal was studied for effects on lipid and metabolic markers in women with metabolic syndrome.

A 16-week, randomized, double-blind, placebo-controlled study (N=29) assessed the acute and chronic effects of a proprietary product OpunDia (Opuntia ficus-indica) on metabolic markers, glycemia, lipid profile, and safety in obese prediabetic men and women.

Evidence strength: Weak. Meta-analysis results show statistically significant but not clinically meaningful changes in BMI and body fat, with high heterogeneity. Weight reduction has not been established as a reliable outcome.

4.6 Metabolic Syndrome

Metabolic syndrome (MetS) is a multifactorial cardiometabolic condition characterized by insulin resistance, visceral adiposity, dyslipidemia, hypertension, and chronic low-grade inflammation. Growing interest has focused on plant-derived dietary strategies capable of targeting multiple pathogenic pathways simultaneously. OFI-derived flavonoids and betalains modulate key components of the redox–inflammatory–metabolic network, including activation of NRF2-mediated antioxidant responses, attenuation of NF-κB and NLRP3-dependent inflammatory signaling, regulation of insulin-related pathways such as IRS-PI3K-AKT and AMPK, and modulation of lipid metabolism through SREBP-1c downregulation and PPAR-α activation, as well as potential interactions with gut barrier integrity and microbiota-related signaling.

A systematic review and meta-analysis of 15 controlled studies (N=1,670) on the effects of Mexican ancestral food consumption on obese patients reported significant reductions in body mass index, as well as differences in body weight, waist circumference, total cholesterol, and triglycerides following ingestion of nopal (Opuntia ficus-indica), among other traditional foods.

Evidence strength: Mechanistic evidence is promising from cell and animal models. Human evidence is limited and often confounded by the use of nopal as part of a broader dietary intervention rather than as an isolated supplement.

4.7 Liver Protection (Hepatoprotection)

Research into OFI's hepatoprotective effects has been conducted primarily in animals. An extract obtained from cladodes, rich in polyphenols (phenolic acids and flavonoids), tocopherols, and pectin, was able to reduce liver steatosis in genetically obese Zucker rats. The same effect was reported in rats with diet-induced steatosis. Moreover, an extract derived from OFI seeds has been shown to reduce liver triglyceride accumulation in animal models. No robust controlled human data for hepatoprotection were identified in available sources.

Evidence strength: Preclinical only. Animal model data are promising but human clinical trials are absent from the reviewed literature.

4.8 Other Areas (Largely Preclinical or Insufficient Evidence)

Antimicrobial activity: The identified natural cactus compounds were shown to be endowed with biologically relevant activities including anti-inflammatory, antioxidant, hypoglycemic, antimicrobial, and neuroprotective properties — but antimicrobial evidence in humans is absent.
Benign prostatic hyperplasia (BPH): There is insufficient evidence to support use of Opuntia ficus-indica for BPH; more studies are needed.
Athletic performance: In a randomized placebo-controlled study (N=10), dietary supplementation with OFI significantly increased high- and low-frequency activity and significantly decreased heart rate in high-level athletes. This single small study is insufficient to draw conclusions.

5. Body Systems and Health Areas of Association

Endocrine / Metabolic: Blood glucose regulation, insulin sensitivity, type 2 diabetes management, metabolic syndrome
Cardiovascular: Lipid profile (LDL, HDL, total cholesterol, triglycerides), blood pressure, platelet function, oxidative damage to LDL
Gastrointestinal: Dietary fiber effects on gut transit, mucilage as a gastric protectant, postprandial glucose blunting through delayed absorption
Hepatic: Preclinical evidence of protection against steatosis and oxidative hepatic damage
Immune/Inflammatory: Modulation of NF-κB, NRF2, inflammatory cytokines (TNF-α, IL-1β), and prostaglandins
Neurological: Neuroprotective properties of nicotiflorin and other flavonoids described in preclinical models
Renal/Urinary: Historical diuretic use; potential interaction with diuretic drugs

6. Dosage Forms and Dosages Reported in Studies

The following dosages are drawn directly from the clinical trial literature described in the sources above:

Broiled/steamed nopal stems: 500 g, consumed as part of a meal; used in multiple hypoglycemic trials by Frati-Munari and colleagues. A single dose of 500 g of broiled nopal stems was studied for its hypoglycemic effect in subjects with diabetes.
Dehydrated nopal extract capsules: 30 capsules containing 10.1 ± 0.3 g of extract; used in fasting glycemia experiments. To assess if a dehydrated extract of nopal stems retains the effect on glycemia of the entire stems, six patients with type II diabetes in fasting condition received 30 capsules containing 10.1 ± 0.3 g of the extract.
Cladode powder: 50 g, assessed in healthy participants for glycemic index. The powder (50 g) significantly lowered serum glucose (p < 0.001) and produced a glycemic index score of 32.5 ± 4.0, and insulinemic index of 36.1 ± 6.1.
Fresh fruit pulp: 250 g once or twice daily for 2 weeks; studied for oxidative stress outcomes. 18 healthy volunteers received either 250 g fresh fruit pulp or 75 mg vitamin C twice daily for 2 weeks, with a 6-week washout period.
NeOpuntia (dehydrated leaf extract): 1.6 g per meal (taken with meals); studied in a 6-week RCT in 68 women with metabolic syndrome. Consumption of dried leaves from O. ficus-indica as a dietary supplement (NeOpuntia 1.6 g per meal for 6 weeks) was associated with changes in cholesterol fractions.
OFI extract for hangover: 1600 IU, given 5 hours before alcohol consumption. In the Wiese et al. (2004) trial, volunteers received OFI (1600 IU) and identical placebo, given 5 hours before alcohol consumption.
Range in meta-analysis: Various dose forms of O. ficus-indica at daily dosages ranging from 400 mg to 15 g for durations of 6 weeks to 2 years were evaluated in the RCT meta-analysis.
Opuntia robusta pulp: 250 g per day for 8 weeks; used in the lipid metabolism study in hypercholesterolemic men.

7. Safety Considerations and Drug Interactions

General Safety Profile

Clinical pharmacologic interest in the efficacy and safety of the phytochemicals present in the genus Opuntia has grown during recent years due to the realization that many people self-medicate using this plant.

Dermatitis

Dermatitis is the most common adverse reaction to prickly pear. Treatment with topical corticosteroids has been recommended.

Gastrointestinal Events

Prickly pear ingestion, especially of the seeds, can cause large bowel obstruction requiring medical intervention.

Hypoglycemia Risk with Antidiabetic Drugs

This is the best-documented and most clinically significant interaction. A case report described the blood glucose-lowering effect of prickly pear cactus (PPC) in a patient concurrently taking oral antihyperglycemics, documenting an episode of hypoglycemia. One patient survey discovered the most common drug-herbal interaction in the given population to be between PPC and antihyperglycemic agents, resulting in hypoglycemia.

A documented case involved: a 58-year-old Mexican male with type 2 diabetes mellitus being treated with metformin 1000 mg twice daily and extended-release glipizide 10 mg daily who reported 4 hypoglycemic events with blood glucose readings of 49–68 mg/dL, which resulted in discontinuation of glipizide.

Prickly pear may theoretically exacerbate hypoglycemia in patients being treated with hypoglycemic agents (e.g., metformin, glyburide, rosiglitazone, acarbose). Prickly pear may also exacerbate diuresis in patients being treated with diuretic agents (e.g., furosemide, hydrochlorothiazide). However, these interactions are not well documented.

Medscape's drug interaction database identifies pharmacodynamic synergism between Opuntia ficus-indica and the following agents, with a caution/monitor recommendation: acarbose, glimepiride, glipizide, glyburide, and insulin aspart, among other antidiabetic drugs.

Pregnancy and Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking.

Allergy and Hypersensitivity

Patients hypersensitive to any components of prickly pear should avoid use.

Regulatory Status

The U.S. Food and Drug Administration regulates dietary supplements; however, it uses a different set of regulations than it does for conventional foods or drugs. Unlike drug manufacturers, the makers of supplements don't have to show their products are safe or effective before selling them on the market. The European Food Safety Authority (EFSA) has specifically reviewed health claims for a commercial cactus extract and did not establish a cause-and-effect relationship for the claimed lipid benefits, as noted above.

References

Health Conditions

Health conditions that Cactus may help support.

No conditions available.

Body Systems

Body systems that Cactus may help support.

No body systems available.